D. Butler

发表

Comparative Analysis of the Antibacterial Activity of a Novel Peptide Deformylase Inhibitor, GSK1322322

M. Hackel, D. Hoban, S. Bouchillon, 2013, Antimicrobial Agents and Chemotherapy.

A Comparative In Vitro Surveillance Study of Gemifloxacin Activities against 2,632 Recent Streptococcus pneumoniaeIsolates from across Europe, North America, and South America

J. Karlowsky, D. Hoban, L. Miller, 2000, Antimicrobial Agents and Chemotherapy.

Potent Sub-MIC Effect of GSK1322322 and Other Peptide Deformylase Inhibitors on In Vitro Growth of Staphylococcus aureus

Dongzhao Chen, M. Zalacain, Karen O'Dwyer, 2013, Antimicrobial Agents and Chemotherapy.

A 5-Year Surveillance Study of 44,691 Isolates ofHaemophilus influenzae Project Beta-Alert 1993–1997

R. L. Kaplan, L. Miller, J. Poupard, 1999, Antimicrobial Agents and Chemotherapy.

Comparative In Vitro Potency of Gemifloxacin and Fluoroquinolones Against Recent European Clinical Isolates from a Global Surveillance Study

D. Hoban, G. Zhanel, L. Miller, 2001, European Journal of Clinical Microbiology & Infectious Diseases.

Cellular Pharmacokinetics and Intracellular Activity of the Novel Peptide Deformylase Inhibitor GSK1322322 against Staphylococcus aureus Laboratory and Clinical Strains with Various Resistance Phenotypes: Studies with Human THP-1 Monocytes and J774 Murine Macrophages

P. Tulkens, F. Van Bambeke, Frédéric Peyrusson, 2015, Antimicrobial Agents and Chemotherapy.

Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study.

D. Hoban, G. Zhanel, L. Miller, 2001, Diagnostic microbiology and infectious disease.

Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae

D. Holmes, L. Miller, Jianzhong Huang, 2015, Antimicrobial Agents and Chemotherapy.

Comparative In Vitro Surveillance of Amoxicillin-Clavulanic Acid and Four Oral Comparators Against 21,232 Clinical Isolates from Europe

D. Hoban, G. Zhanel, L. Miller, 2003, European Journal of Clinical Microbiology and Infectious Diseases.

In vitro activity of gepotidacin against urine isolates of Escherichia coli from outpatient departments in Germany.

G. Werner, Y. Pfeifer, M. Kresken, 2022, Journal of Antimicrobial Chemotherapy.

In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study.

D. Hoban, L. Miller, J. Poupard, 2004, International journal of antimicrobial agents.

Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020)

M. Castanheira, R. Mendes, S. Arends, 2023, Antimicrobial agents and chemotherapy.

Escherichia coli ATCC 35218 as a Quality Control Isolate for Susceptibility Testing of Haemophilus influenzae with Haemophilus Test Medium

L. Miller, J. Poupard, C. Jakielaszek, 1999, Antimicrobial Agents and Chemotherapy.

Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander Project 1992-1996.

L. Miller, J. Poupard, D. Felmingham, 1999, The Journal of antimicrobial chemotherapy.

In Vitro and Intracellular Activities of Peptide Deformylase Inhibitor GSK1322322 against Legionella pneumophila Isolates

J. Martel, J. Dubois, Kelly M. Aubart, 2014, Antimicrobial Agents and Chemotherapy.

Comparative in vitro potency of amoxycillin-clavulanic acid and four oral agents against recent North American clinical isolates from a global surveillance study.

D. Hoban, G. Zhanel, L. Miller, 2003, International journal of antimicrobial agents.

Comparative Analysis of the Antibacterial Activity of a Novel Peptide Deformylase Inhibitor, GSK1322322

M. Hackel, D. Hoban, S. Bouchillon, 2013, Antimicrobial Agents and Chemotherapy.